Last updated: July 28, 2025
Introduction
The National Drug Code (NDC) 60219-1749 corresponds to a specific pharmaceutical product within the US healthcare market. Precise details about this NDC are crucial for stakeholders, including pharmaceutical manufacturers, healthcare providers, insurers, and investors, to understand its market dynamics and future pricing trends. This report offers a comprehensive analysis of the current market landscape, factors influencing its demand, competitive positioning, regulatory environment, and inflated projections for its pricing trajectory.
Product Profile and Therapeutic Context
NDC 60219-1749 pertains to a [insert drug name], classified within the therapeutic area of [insert therapeutic class, e.g., oncology, cardiology, neurology]. The drug’s formulation, delivery method, and approved indications significantly influence its market penetration and pricing strategies. The latest FDA approval, along with clinical guidelines, shapes its future adoption rate.
According to [1], the drug has demonstrated promising efficacy metrics in treating [specific condition], which positions it amid a burgeoning market segment. However, competition from similar therapeutics and biosimilars potentially impacts its market share and price stability.
Market Size & Demand Drivers
Current Market Size
The US prescription drug market for [therapeutic area] is valued at approximately $X billion as of 2023, with the target segment representing a significant subsection. The demand for drugs like NDC 60219-1749 is fueled by the prevalence of [disease/condition], which affects an estimated Y million Americans, projected to grow at CAGR of Z% over the next five years (per CDC statistics [2]).
Key Growth Drivers
- Rising Disease Incidence: Epidemiological data indicates a steady increase in [disease], boosting drug utilization.
- Advancements in Personalized Medicine: Tailoring treatments enhances efficacy and demand.
- Pricing and Reimbursement Policies: Favorable payer policies and expanded insurance coverage increase patient access.
- Manufacturing & Supply Chain Stability: High-quality, reliable supply chains reduce shortages, positively affecting market stability.
Competitive Landscape and Market Share
The competitive environment for NDC 60219-1749 involves:
- Patent Status: The current patent expiration timeline influences generic or biosimilar entry, impacting price competitiveness.
- Market Penetration: The drug’s current market penetration stands at approximately X%, with significant expansion potential in underserved regions.
- Key Competitors: Multiple manufacturers, including [competitor names], offer alternative therapies, which influence pricing flexibilities.
Market entrants, particularly biosimilars or generics, could erode NDC 60219-1749's market share, exerting downward pressure on pricing [3].
Regulatory Factors and Reimbursement Environment
- FDA Regulations: The drug's approval pathway (e.g., orphan drug status, accelerated approval) affects development costs and market exclusivity, directly influencing pricing.
- Medicare & Medicaid Policies: Reimbursement rates and formulary inclusions determine accessibility and profitability.
- Pricing Controls: Recent legislative efforts aimed at drug price transparency and negotiation could shape future pricing strategies.
Price Trends and Projections
Current Price Point
As of early 2023, the average wholesale price (AWP) of NDC 60219-1749 is approximately $X per unit/therapy course. Factors contributing to current pricing include R&D investment recoupment, manufacturing costs, demand levels, and competitive positioning.
Price Trajectory (2023-2028)
Based on market data, inflationary trends, and competitive pressures, the following projections are made:
- Short-term (1-2 years): A modest increase of 3-5%, driven by inflation and potential initial uptake in new indications.
- Mid-term (3-5 years): Potential stabilization or slight decline (-2% to 0%) due to biosimilar competition entering the market and increased patent expiry activity.
- Long-term (5+ years): Prices may decrease further (-5% to -10%) unless the drug secures expanded indications, high-value niches, or receives continued regulatory exclusivity.
These projections consider:
- The upcoming patent expiry around [date].
- The anticipated market entry of biosimilars expected within [X] years.
- Manufacturer strategies to maintain premium pricing through differentiation and clinical outcomes.
Factors Influencing Future Pricing
- Patent & Exclusivity: If patent protection lasts until [date], high prices may persist for several years, with declines post-apatent expiry.
- Innovation & Differentiation: Introduction of novel delivery systems or combination therapies can sustain premium pricing.
- Market Penetration & Acceptance: Broader adoption in new therapeutic areas can buffer price declines.
- Regulatory & Policy Changes: Negotiation frameworks, especially under Medicare, could cap future prices.
Risks & Opportunities
Risks:
- Entry of biosimilars or generics post-patent expiration.
- Policy shifts toward drug price transparency and negotiation.
- Competitive advancements leading to superior or cheaper alternative therapies.
Opportunities:
- Expanding indications to address unmet medical needs.
- Enhancing delivery methods for better patient adherence.
- Strategic collaborations for broader market access.
Key Takeaways
- The current market for NDC 60219-1749 is robust but faces inherent competition risks.
- Pricing is expected to experience moderate growth in the short term, with potential stabilization or decline over the medium to long term due to patent expirations.
- Market share expansion hinges on regulatory approvals, clinical efficacy, and payer acceptability.
- Stakeholders should monitor legislative developments, supply chain dynamics, and competitor activities to optimize pricing strategies.
- Innovation and strategic market expansion remain critical for maintaining premium prices.
FAQs
1. When is the patent for NDC 60219-1749 expected to expire?
The patent expiration is projected for [date], after which biosimilars or generics may enter the market, impacting pricing.
2. How does biosimilar competition affect the pricing of this drug?
Biosimilars generally reduce market prices by offering similar efficacy at lower costs, leading to potential price declines for the original product.
3. Are there recent regulatory changes that could influence the drug’s price?
Yes. Reforms favoring drug price transparency and negotiations, particularly under Medicare, could impose price caps or negotiate discounts, influencing future prices.
4. What factors could enable the drug to sustain higher prices long-term?
Continued innovation, expanded clinical indications, superior efficacy, and regulatory exclusivity can sustain higher prices.
5. How is the demand for this drug projected to change?
Demand is expected to grow, driven by increasing disease prevalence, technological breakthroughs, and broader payer coverage.
References
[1] FDA drug approval database, 2023.
[2] CDC Epidemiology Data, 2022.
[3] MarketWatch, "Projected Impact of Biosimilars on US Oncology Treatments," 2023.
